Vaccine against toxic shock syndrome in a first-in-man clinical trial
Main Authors: | Andreas Roetzer, Bernd Jilma, Martha M. Eibl |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-02-01
|
Series: | Expert Review of Vaccines |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14760584.2017.1268921 |
Similar Items
-
High Titer Persistent Neutralizing Antibodies Induced by TSST-1 Variant Vaccine Against Toxic Shock Cytokine Storm
by: Andreas Roetzer, et al.
Published: (2020-10-01) -
A randomized, double-blind study on the safety and immunogenicity of rTSST-1 variant vaccine: phase 2 resultsResearch in context
by: Christian Schoergenhofer, et al.
Published: (2024-01-01) -
Some immunological responses in rats injected with prepared bacterin toxoid of local methicillin resistant Staphylococcus aureus
by: Abdullah A. Sheehan, et al.
Published: (2022-04-01) -
Staphylococcal Toxic Shock Syndrome Caused By An Intravaginal Product. A Case Report
by: Marton Monica
Published: (2016-01-01) -
An overlooked cause of septic shock: Staphylococcal Toxic Shock Syndrome secondary to an axillary abscess
by: Bidhya Poudel, et al.
Published: (2021-01-01)